MRI
ProcedureMultimodal neuroimaging on 3T Prisma Fit MRI
NCT Number: NCT05430490
This study employs novel methods to identify key determinants and consequences of concurrent HIV infection and regular cannabis use. This study will acquire extensive phenotype data from peripheral and brain markers of immune activation, brain structure, and neuropsychological performance (NP) in persons living with HIV (PLWH) receiving combination anti-retroviral therapy (cART) (80 regular cannabis users and 80 non-users) and HIV uninfected (HIV-) controls (80 regular cannabis users and 80 non-users). This study will provide key insights into the effects of regular cannabis and HIV on peripheral and brain markers of immune function and NP in PLWH and HIV- controls. These insights are critical for cure strategies and ongoing HIV treatment initiatives.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Washington University School of Medicine, St Louis, Missouri, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Multimodal neuroimaging on 3T Prisma Fit MRI
A series of written, verbal, and motor tasks requiring the participant to follow instructions, remember words and numbers, draw objects, and complete timed actions.
Laboratory reports (CMP, CBC, Lipids)
Life history, current behaviors, and substance use surveys
Optional procedure which involves obtaining cerebral spinal fluid through a needle in the lower back
Time frame: Years 1-5
Validated plasma and cerebrospinal fluid (CSF) markers of immune health and inflammation (e.g., CD14, CD16, Neopterin, etc.), as well as novel neuroimaging methods of neuro-inflammation (e.g., DTI & DBSI, 3T MRI) will be used to evaluate brain inflammation.
Time frame: Years 1-5
Neuropsychological assessment results will be normed and converted into Z scores for comparison with brain volumes calculated from the 3T.
Washington University School of Medicine
Other
Acronym: CHAMPS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05554146
Blood-Borne Infections, Cannabis
The Bronx, New York, United States
View Trial DetailsNCT04866004
Blood-Borne Infections, Chemically-Induced Disorders
Houston, Texas, United States
View Trial DetailsNCT00079560
Blood-Borne Infections, Chemically-Induced Disorders
New York, United States
View Trial DetailsNCT05388474
Blood-Borne Infections, Communicable Diseases
Los Angeles, California, United States
View Trial Details